New HPV Self-Testing Method Improves Cervical Cancer Screening
A new method for HPV self-testing stratifies women into three risk groups, enhancing cervical cancer screening and follow-up care.
Read MorePosted by Andy Lundin | Dec 13, 2024 | Cervical (HPV) |
A new method for HPV self-testing stratifies women into three risk groups, enhancing cervical cancer screening and follow-up care.
Read MorePosted by Andy Lundin | Dec 12, 2024 | Cancer |
Lunit’s Universal Immunohistochemistry AI model analyzes diverse cancer types and IHC stains, enabling accurate biomarker analysis.
Read MorePosted by Andy Lundin | Dec 10, 2024 | Cardiovascular |
Eko Health’s AI-powered SENSORA platform has received a Category III CPT code, paving the way for improved heart disease detection.
Read MorePosted by Andy Lundin | Dec 5, 2024 | Molecular Diagnostics |
Researchers have identified a potential epigenetic biomarker for preeclampsia, offering hope for earlier diagnosis and intervention.
Read MorePosted by Andy Lundin | Dec 4, 2024 | Cancer, Prenatal Testing |
NIH researchers found undetected cancers in nearly half of pregnant people with abnormal prenatal cfDNA test results.
Read More